Diagnosing Torsades De Pointes Based on Correlation to QT Interval: A Systematic Review

被引:4
|
作者
Kahlon, Simranjit S. [1 ]
Sikandar, Rabia [1 ]
Tejovath, Sreedevi [1 ]
Nair, Shaalina [1 ]
Hassan, Danial [2 ,3 ]
Patel, Khushbu K. [1 ]
Peddemul, Aishwarya [4 ]
Mostafa, Jihan A. [1 ]
机构
[1] Calif Inst Behav Neurosci & Psychol, Internal Med, Fairfield, CA 94534 USA
[2] Minist Publ Hlth, Epidemiol & Publ Hlth, Doha, Qatar
[3] Calif Inst Behav Neurosci & Psychol, Cardiol, Fairfield, CA USA
[4] Calif Inst Behav Neurosci & Psychol, Obstet & Gynecol, Fairfield, CA USA
关键词
qt prolongation and risk of torsades; drug-induced long qt syndrome; torsades; torsades de pointes (tdp); qt interval prolongation; long qt syndrome; VENTRICULAR REPOLARIZATION; PROLONGATION; AFTERDEPOLARIZATIONS; ARRHYTHMIAS;
D O I
10.7759/cureus.27833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Torsades de Pointes (TdP) is a rare form of tachyarrhythmia which can potentially be fatal due to its tendency to degenerate into ventricular fibrillation. It is described as a polymorphic ventricular tachycardia characterized by twisting of the QRS complexes around the electrocardiogram (ECG) baseline in patients with a prolonged QT interval. Prolonged QT interval is known as long QT syndrome.Torsades de Poccurs most commonly in patients with an extended QT interval duration, and even though monitoring an ECG can assist in its prevention, there is no defined duration of a QT interval that can lead to an increased risk of Torsades de Pointes. So, it is hard to determine what QT interval constitutes enough risk for Torsades de Pointes to require intervention. The QT interval duration also depends on other factors, namely heart rate (HR) and other factors such as drugs, congenital diseases, and a combination of both.In this study, we considered various causes of QT prolongation but mainly focused on congenital diseases, drugs, or perioperative risk of QT prolongation and the correlation with the risk of impending TdP. By following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and researching studies on various databases, namely PubMed, Science Direct, Medline, and CiNii we were able to find various systematic reviews and articles showing the association between prolonged QT interval and its degeneration into TdP. This review encourages further research into this topic to understand the implications of QT prolongation and how it can help save the lives of patients with known long QT syndrome, or those on QT prolonging drugs with simple ECG monitoring and treatment for the respective cause.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Donepezil - QT prolongation and torsades de pointes
    Malik, Bilal Haider
    CLINICAL MEDICINE, 2019, 19 (02) : 189 - 189
  • [32] QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes
    Alan David Kaye
    Jacqueline Volpi-Abadie
    J. Michael Bensler
    Adam M. Kaye
    James H. Diaz
    Journal of Anesthesia, 2013, 27 : 575 - 587
  • [33] Evaluating the risk of Torsades de pointes with fluoroquinolones: an analysis of QT-interval and QT-dispersion.
    Peeters, MJ
    Tsikouris, JP
    Cox, CD
    Meyerrose, GE
    Seifert, CF
    PHARMACOTHERAPY, 2004, 24 (10): : 1424 - 1424
  • [34] QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes
    Kaye, Alan David
    Volpi-Abadie, Jacqueline
    Bensler, J. Michael
    Kaye, Adam M.
    Diaz, James H.
    JOURNAL OF ANESTHESIA, 2013, 27 (04) : 575 - 587
  • [35] Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?
    Samuelov-Kinori, Liat
    Kinori, Michael
    Kogan, Yevgeni
    Swartzon, Michael
    Shalev, Hadas
    Guy, Daniel
    Ferenidou, Fotini
    Mashav, Noa
    Sadeh, Ben
    Atzmony, Lihi
    Kliuk-Ben-Basat, Orit
    Steinvil, Arie
    Justo, Dan
    JOURNAL OF ELECTROCARDIOLOGY, 2009, 42 (04) : 353 - 357
  • [36] PROLONGED QT INTERVAL AND TORSADES-DE-POINTES AFTER THERAPY WITH PRENYLAMIN (SEGONTIN)
    BURRI, C
    AJDACIC, K
    MICHOT, F
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1981, 70 (16): : 717 - 720
  • [38] TORSADES-DE-POINTES AND PROLONGATION OF THE DURATION OF QT INTERVAL FOLLOWING THE INJECTION OF DROPERIDOL
    GUY, JM
    ANDREFOUET, X
    PORTE, J
    BERTRAND, M
    LAMAUD, M
    VERNEYRE, H
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1991, 40 (09): : 541 - 545
  • [39] QT interval lengthening after fasting complicated by a sudden attack of Torsades de Pointes
    Petrov, DB
    TEXAS HEART INSTITUTE JOURNAL, 2003, 30 (01) : 86 - 87
  • [40] QT interval prolongation as a biomarker for torsades de pointes and sudden death in drug development
    Sides, GD
    DISEASE MARKERS, 2002, 18 (02) : 57 - 62